LFMD
LifeMD, Inc.
$4.88
-0.03 (-0.61%)
At close · Jul 7
Market Cap
$236.01M
Shares
48,362,510
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.88
Open$4.92
Day$4.79–5.01
52W$2.56–12.72
Avg vol 30d1.0M
Short int5.9M · 12.1% float · 6.6d
Short vol61%
Last earningsMay 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+12%
above
Price vs 50-day avg
+6%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
23%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+16%
trailing
YTD return
+43%
this year
Relative strength
+9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
2 of 102 funds reported for Jun 30 · net -116 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.13% of float · ▲ +5.0% MoM · 6.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 3-yr range
Squeeze score
75
high risk · 0–100
Fundamentals
Revenue growth
+50%
Y/Y
Gross margin
1334%
contracting
EPS growth
+142%
Y/Y
Free cash flow
$6.4M
Balance sheet
$35.0M
net cash
Quant / Vol
risk profile
Volatility
92%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
7.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 6, 2026
Revenue
· full year 2026
Initiated
$220M – $230M
prior FY $194.06M
midpoint +15.9% Y/Y
Adjusted EBITDA
· full year 2026
Initiated
$12M – $17M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+12%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
23%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
2 of 102 funds reported for Jun 30 · net -116 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.13% of float · ▲ +5.0% MoM · 6.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $5 · 23%
52-wk high $13
vs 200-day avg +12%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| active telehealth subscribers | 365,000 | Q1 2026 | — |
| adjusted EBITDA loss non-GAAP | -$4.5M | Q1 2026 | — |
| net telehealth subscribers added | 42,000 | Q1 2026 | — |
| Weight Management program subscribers | 100,000 | Q1 2026 | — |
| active patients | 215K | Q1 call | — |
| active subscribers | 365K | Q1 call | — |
| covered lives | 112M | Q1 call | — |
| pharmacy prescriptions per month | 20K | Q1 call | — |
| subscribers | 365K | Q1 call | — |
| Adjusted EBITDA non-GAAP | $4,759K | Three Months Ended Dec. 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LFMD
this stock
LifeMD, Inc.
|
$236.01M | +43.1% | +126.1% | — | 12.1% |
|
VEEV
Veeva Systems Inc
|
$30.57B | -15.7% | +28.1% | 33.4 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.67B | -9.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.67B | +88.3% | -0.4% | 50.4 | 4.8% |
|
TEM
Tempus AI, Inc.
|
$10.79B | +1.8% | +65.8% | — | 21.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LFMD | +16.2% | -0.2% | +16.5% | +18.2% | +43.1% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +15.3% | -1.6% | +8.9% | +18.0% | +33.5% |